ArticleFrontiers in endocrinology2025

Protective effects of Shenkang injection against diabetic kidney disease via p38 MAPK/NFκB/MCP-1/CCR2 pathway inhibition.

Xin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.